Recent advances in cardiac beta(2)-adrenergic signal transduction.
about
Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: a disease susceptibility polymorphismCardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative StressThird-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failureNuclear GPCRs in cardiomyocytes: an insider's view of β-adrenergic receptor signalingActivation of β-adrenergic receptors is required for elevated α1A-adrenoreceptors expression and signaling in mesenchymal stromal cells.GIPC interacts with the beta1-adrenergic receptor and regulates beta1-adrenergic receptor-mediated ERK activationProtein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted systemTargeted inactivation of Galpha(i) does not alter cardiac function or beta-adrenergic sensitivityGreater glycogen utilization during 1- than 2-adrenergic receptor stimulation in the isolated perfused rat heartTemporal dynamics of inotropic, chronotropic, and metabolic responses during beta1- and beta2-AR stimulation in the isolated, perfused rat heartRGS2 is a primary terminator of β₂-adrenergic receptor-mediated G(i) signalingbeta2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscleThe structure and function of G-protein-coupled receptorsCalcineurin, a calcium/calmodulin-dependent protein phosphatase, is involved in movement, fertility, egg laying, and growth in Caenorhabditis elegans.Using models of the myocyte for functional interpretation of cardiac proteomic data.C825T G-protein beta3 subunit gene polymorphism, tilt test results and point score in syncopal patients.Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytesG protein, phosphorylated-GATA4 and VEGF expression in the hearts of transgenic mice overexpressing β1- and β2-adrenergic receptors.Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through beta 2-adrenoceptors.Modeling the actions of beta-adrenergic signaling on excitation--contraction coupling processesCaveolae create local signalling domains through their distinct protein content, lipid profile and morphologyLow-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving beta-blocking agents.Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathy.Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.Pharmacological support for children with myocardial dysfunction.Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling.Receptor crosstalk. Implications for cardiovascular function, disease and therapy.THE ROLE OF β-ADRENERGIC RECEPTORS IN HEART FAILURE: DIFFERENTIAL REGULATION OF CARDIOTOXICITY AND CARDIOPROTECTION.A common variant in the β2-adrenergic receptor and risk of sudden cardiac death.Beta-blockade in heart failure: selective versus nonselective agents.Different subcellular populations of L-type Ca2+ channels exhibit unique regulation and functional roles in cardiomyocytesThr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy.Selective β2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury.Beta 2-adrenergic receptor signaling acts via NO release to mediate ACh-induced activation of ATP-sensitive K+ current in cat atrial myocytesDrug discovery for heart failure: a new era or the end of the pipeline?The influence of diabetes on cardiac beta-adrenoceptor subtypes.Arrhythmogenic effects of beta2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load.Role of adenylyl cyclase in reduced β-adrenoceptor-mediated vasorelaxation during maturation.Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.
P2860
Q24683351-9628B96C-DBB6-4DFE-8592-EE1F2EB185C4Q26773004-E6421B38-8BAA-4E3A-A095-1CE1C6D43F0DQ26822825-2164ED32-13C5-4C0F-B2FF-DCD6F166FE5FQ27026973-46FCF670-EA11-4CCD-B60A-1B4EDD963906Q27312408-B99AF7CB-E106-4D43-A46F-6E1770DCD768Q28201893-7D3409C2-25B3-4152-9E88-09E3FD467EB4Q28204412-791EF4AF-1F49-46AA-8202-D05B56F62C43Q28506805-085037D5-6ACC-42B7-AA47-8B1A88CAF7EAQ28564256-E6DFEBE1-5AFA-45A3-B63E-B4D64A8FA36EQ28568229-583215BB-86DB-491F-ADC8-3BBF35598151Q28580341-860836FF-9140-45A3-BA9B-10FC143B1D47Q28582641-8DB96F73-62B2-4D0B-973C-3B2E543657B4Q29616792-810F5EF3-40A7-4281-BA60-140C61067453Q30846950-DBBEC374-5017-44AB-BF36-32765EE0B23AQ30978949-71994222-B436-40AB-B991-8FBE006C8BC6Q33156300-7C29A041-CE94-4F86-B4CC-85A84DBD1D1DQ33181618-8EC140FC-A6BE-456F-8526-3421F41669FAQ33702011-E4C7C7DC-52F8-4A80-86C2-80CCCAAC1755Q33717958-600EE62E-D13A-4A38-9E63-BDBAC4D7EE64Q33947615-5A3FDC18-6CEE-4F0E-865D-0138CED3181DQ33998121-DCBB6DEA-0CA1-4860-938B-BABA51CD6A23Q34221055-F47065C1-A1D6-46E6-A8D8-A70B97D61E40Q34250888-31A0A498-498B-4B53-9B68-1B5F12EA382AQ34403963-9C8B5541-F707-4A74-B3F4-BD7D4316DCBAQ34449709-C05CCFCF-5B87-4E9A-9460-CAB7E359E180Q34534627-D4533279-184C-4C79-9F82-0B84074F93C1Q34586280-461CBFF1-75F9-4EE4-8AEC-B3B0B34D9834Q34920635-87AD2F5F-782B-40B4-B642-6D85FCE7D48CQ35104064-9D359CA1-E10B-4E86-B17D-16BA85704AD6Q35576506-E0BB9FA0-6D06-46B1-A65A-7E203D2B3515Q35631382-35F2C88F-412F-48D0-BAED-69EECD9DCE7EQ35690709-CE3A5198-5ED3-4043-93C0-947350386879Q36014089-FBAD4639-2AD1-4658-B791-BEECBB90732DQ36106686-1024D3FD-FF85-4F82-B86F-B031A1D3B5C5Q36445252-D79BE31C-32A3-4718-93CD-3EA985F67D48Q36724656-E5475303-95AD-4749-A847-976A7A330974Q36761301-B8D9B404-3DAB-4C45-906E-802323595900Q36980296-BFB2B9FA-94C1-42FE-8581-522B92986B77Q37088360-D6F1865E-83E3-4158-8AE0-1B65521ADA09Q37129351-0C9E0C3C-B76A-4556-8440-35E4454B9548
P2860
Recent advances in cardiac beta(2)-adrenergic signal transduction.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Recent advances in cardiac beta(2)-adrenergic signal transduction.
@ast
Recent advances in cardiac beta(2)-adrenergic signal transduction.
@en
type
label
Recent advances in cardiac beta(2)-adrenergic signal transduction.
@ast
Recent advances in cardiac beta(2)-adrenergic signal transduction.
@en
prefLabel
Recent advances in cardiac beta(2)-adrenergic signal transduction.
@ast
Recent advances in cardiac beta(2)-adrenergic signal transduction.
@en
P2093
P921
P1433
P1476
Recent advances in cardiac beta(2)-adrenergic signal transduction.
@en
P2093
P304
P356
10.1161/01.RES.85.11.1092
P577
1999-11-01T00:00:00Z